Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis C

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 27 articles:
HTML format
Text format



Single Articles


    March 2018
  1. LIANG TJ, Ward JW
    Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic.
    N Engl J Med. 2018;378:1169-1171.
    PubMed     Text format    


    January 2018
  2. ZEUZEM S, Foster GR, Wang S, Asatryan A, et al
    Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
    N Engl J Med. 2018;378:354-369.
    PubMed     Text format     Abstract available


  3. GUPTA A, Jain P
    Calcified Spleen and Gallstones.
    N Engl J Med. 2018;378:380.
    PubMed     Text format    


    October 2017
  4. GANE E, Lawitz E, Pugatch D, Papatheodoridis G, et al
    Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.
    N Engl J Med. 2017;377:1448-1455.
    PubMed     Text format     Abstract available


    September 2017
  5. GOLDBERG DS, Abt PL, Reese PP
    Transplanting HCV-Infected Kidneys into Uninfected Recipients.
    N Engl J Med. 2017;377:1105.
    PubMed     Text format    


  6. MARTINS PN, Movahedi B, Bozorgzadeh A
    Transplanting HCV-Infected Kidneys into Uninfected Recipients.
    N Engl J Med. 2017;377:1104-5.
    PubMed     Text format    


  7. HALLECK F, Budde K, Duerr M, Staeck O, et al
    Transplanting HCV-Infected Kidneys into Uninfected Recipients.
    N Engl J Med. 2017;377:1103-4.
    PubMed     Text format    


    August 2017
  8. REILLEY B, Leston J
    A Tale of Two Epidemics - HCV Treatment among Native Americans and Veterans.
    N Engl J Med. 2017;377:801-803.
    PubMed     Text format    


    June 2017
  9. BOURLIERE M, Gordon SC, Flamm SL, Cooper CL, et al
    Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
    N Engl J Med. 2017;376:2134-2146.
    PubMed     Text format     Abstract available


    April 2017
  10. GOLDBERG DS, Abt PL, Blumberg EA, Van Deerlin VM, et al
    Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.
    N Engl J Med. 2017 Apr 30. doi: 10.1056/NEJMc1705221.
    PubMed     Text format    


    November 2016
  11. LEVITSKY J, Verna EC, O'Leary JG, Bzowej NH, et al
    Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients.
    N Engl J Med. 2016;375:2106-2108.
    PubMed     Text format    


    October 2016
  12. MACIOCIA N, O'Brien A, Ardeshna K
    Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection.
    N Engl J Med. 2016;375:1699-1701.
    PubMed     Text format    


    July 2016
  13. PETERS PJ, Pontones P, Hoover KW, Patel MR, et al
    HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.
    N Engl J Med. 2016;375:229-39.
    PubMed     Text format     Abstract available


    April 2016
  14. ASSY N, Barhoum M
    Sofosbuvir and Velpatasvir for Patients with HCV Infection.
    N Engl J Med. 2016;374:1687-9.
    PubMed     Text format     Abstract available



  15. Sofosbuvir and Velpatasvir for Patients with HCV Infection.
    N Engl J Med. 2016;374:1687-9.
    PubMed     Text format     Abstract available


  16. FELD JJ, Zeuzem S
    Sofosbuvir and Velpatasvir for Patients with HCV Infection.
    N Engl J Med. 2016;374:1688-9.
    PubMed     Text format    


  17. CURRY MP, Charlton M
    Sofosbuvir and Velpatasvir for Patients with HCV Infection.
    N Engl J Med. 2016;374:1688.
    PubMed     Text format    


    November 2015
  18. WARD JW, Mermin JH
    Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  19. FOSTER GR, Afdhal N, Roberts SK, Brau N, et al
    Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  20. FELD JJ, Jacobson IM, Hezode C, Asselah T, et al
    Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  21. CURRY MP, O'Leary JG, Bzowej N, Muir AJ, et al
    Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  22. FONTAINE H, Lazarus A, Pol S, Pecriaux C, et al
    Bradyarrhythmias Associated with Sofosbuvir Treatment.
    N Engl J Med. 2015;373:1886-8.
    PubMed     Text format    


    September 2015
  23. LIAO JM, Fischer MA
    Early Patterns of Sofosbuvir Utilization by State Medicaid Programs.
    N Engl J Med. 2015;373:1279-81.
    PubMed     Text format    


    August 2015
  24. WILKIN T
    Primary Care for Men Who Have Sex with Men.
    N Engl J Med. 2015;373:854-862.
    PubMed     Text format     Abstract available


    July 2015
  25. REESE PP, Abt PL, Blumberg EA, Goldberg DS, et al
    Transplanting Hepatitis C-Positive Kidneys.
    N Engl J Med. 2015;373:303-5.
    PubMed     Text format    


  26. NAGGIE S, Cooper C, Saag M, Workowski K, et al
    Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  27. WYLES DL, Ruane PJ, Sulkowski MS, Dieterich D, et al
    Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: